The following discussion is an archived proposal of the WikiProject below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the project's talk page (if created) or the WikiProject Council). No further edits should be made to this page.
The proposed WikiProject was not created. Archiving old proposal. Ajpolino (talk) 01:45, 22 October 2019 (UTC)[reply]
The Global mHealth Standardization Initiative is a global collaborative consensus driven process of Global mHealth open standards development. The Global mHealth Standardization Initiative Portal serves as the project's open access collaborative workspace for GMHSI's virtual community, multilateral multiagency standards & requirements submission hub, and computational modeling results publication repository which is continuously updated & maintained to identify, measure and publish current interagency duplication of efforts or gaps requiring new legislation, regulations, and standards,. Importantly, the portal serves as the platform for transparent non discriminatory interagency collaboration in the examination, convergence, and harmonization of existing standards & open standards, best practices, and policies that reinforce each other, and can be aligned, expanded and further developed into sustainable scalable Global mHealth Open Standards.
Ministry of Science and Technology
Depending on the product being exported to China, a company may need to register with the General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China AQSIQ. China's State Quality Control Administration enacts and implements national standards.
Japan The main regulatory body for creating laws and standards for medical devices and drugs in Japan is the Ministry of Health, Labour and Welfare (Japan)MHLW. Under the MHLW is the Pharmaceutical and Food Safety Bureau. This bureau is in charge of setting pharmaceutical and medical device regulatory policy.
KoreaKFDA The Korean Food and Drug Administration resembles the FDA of the United States. It was established in 1998 and regulates foods, pharmaceuticals, medical devices and cosmetics. The KFDA is divided into five bureaus, including the Pharmaceutical Safety Bureau and the Medical Device Safety Bureau. These bureaus hold primary responsibility for pharmaceutical and medical device regulations. In addition to its main office in Seoul, the KFDA also has six regional offices that serve as field operational bases.
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the project's talk page (if created) or at the WikiProject Council). No further edits should be made to this page.